Studies reporting the baseline determinants of cognitive performance and treatment effect on cognition in patients with multiple sclerosis (MS) are limited. We investigated the baseline correlates of cognition and the long-term treatment effects of fingolimod 0.5 mg once daily on cognitive processing speed and attention in patients with relapsing-remitting MS.

中文翻译：

---

芬戈莫德对复发缓解型多发性硬化患者认知能力的基线特征和影响

报告多发性硬化症 (MS) 患者认知表现的基线决定因素和治疗对认知的影响的研究有限。我们调查了认知的基线相关性和芬戈莫德 0.5 mg 每日一次对复发缓解型 MS 患者认知处理速度和注意力的长期治疗效果。